Last updated: March 4, 2022
Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Habit Reversal
Asperger's Disorder
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT05254769
NFB
Ages 7-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 7 to 17 year olds (diagnosed by their physician with autism, in accordance with DSM-V (Diagnostic Statistical Manual-V) diagnostic criteria
Exclusion
Exclusion Criteria: Any child with a history of
- Brain injury
- Bipolar Disorder
- Tourette's Syndrome
- Uncontrolled seizure disorder
- Major psychiatric disorder
- Children on medications
Study Design
Total Participants: 35
Study Start date:
November 15, 2021
Estimated Completion Date:
May 31, 2022
Study Description
Connect with a study center
Federal Medical and Dental College, Shaheed Zulfiqar Ali Bhutto Medical University
Islamabad, 44000
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.